Device Maker Biomet Builds Second Production Base In China
This article was originally published in PharmAsia News
Executive Summary
U.S.-based medical device manufacturer Biomet recently began construction of its second production base in Changzhou High-tech District. The new facility will mainly produce orthopedic implants. Biomet aims to build up the $15 million production base to become China's medical device manufacturing center. Identifying the medical device industry as a key sector, Changzhou High-tech District has congregated a group of device makers such as Kanghui Medical Innovation, Trauson (Jiangsu) Medical Instrument and Orthmed Medical Instrument. The district will also set up a quality platform to accept international industrial capital transfers and boost the region's economic development. (Click here for more - Chinese Language)
You may also be interested in...
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.